An official website of the United States government
Value Set and Code System Information
| Code System Name | NullFlavor |
| Value Set Code | PHVS_Exposure_NWS |
| Value Set Name | Exposure (NWS) |
| Value Set Version | 1 |
Value Set Concept Details
| Concept Code | OTH |
| Preferred Concept Name | Other |
| Value Set Concept Status | Published |
| Value Set Concept Status Date | 06/12/2025 |
| Value Set Concept Description | |
| Sequence |
Code System Concept Details
| Code System Concept Name | other |
| Code System Concept Status | Published |
| Code System Preferred Concept Name | other |
| Date Created | |
| Date Revised | 05/01/2009 |
Associated Value Sets
| Value Set Name | Version(s) | |
|---|---|---|
| Birth Attendees (NETSS) | 1 | |
| AR Agent (RIBD) | 2 , 1 | |
| ATI Method (RIBD) | 2 , 1 | |
| Acinetobacter culture result (ARLN) | 1 | |
| Activity Type (Brucellosis) | 2 , 1 | |
| Activity Type (Leptospirosis) | 1 | |
| Activity Type Anthrax | 1 | |
| Actual Route of Administration (Anthrax) | 1 | |
| Acute Illness Complications (Pediatric Flu) | 1 | |
| Additional Site of Disease (TB) | 1 | |
| Adverse Event Severity (Malaria) | 2 , 1 | |
| Age unit | 2 | |
| Animal Ownership (Brucellosis) | 2 , 1 | |
| Animal Species (Animal Rabies) | 1 | |
| Animal Type (Anthrax) | 1 | |
| Animal Type (Brucellosis) | 1 | |
| Animal Type (COVID-19) | 1 | |
| Animal Type (FDD) | 3 , 2 , 1 | |
| Animal Type (Leptospirosis) | 2 , 1 | |
| Antacids (FDD) | 1 | |
| Antibiotic Dose Units (Brucellosis) | 3 , 2 | |
| Antibiotic Reason (RIBD) | 1 | |
| Antibiotic Received (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
| Antibiotic Received (RIBD) | 2 , 1 | |
| Antibiotic Treatment (NETSS) | 1 | |
| Antibiotics (FDD) | 5 , 4 , 3 , 2 , 1 | |
| Antimicrobial Agent (IPD) | 1 | |
| Assisted Living Exposure Type (RIBD) | 1 | |
| Associated Conditions (NETSS) | 1 | |
| Bacterial Infection Syndrome (IPD) | 1 | |
| Bacterial Infection Syndrome (NETSS) | 1 | |
| Batch Deactivation Reason | 1 | |
| Binational Reporting Criteria (BIDS) | 1 | |
| Bird Type (RIBD) | 1 | |
| Birth Attendant Titles (NCHS) | 3 | |
| Birth Attendees (VPD) | 1 | |
| Birth Country | 7 , 6 , 5 , 4 | |
| Birth Location (Listeria) | 1 | |
| Birth Location (RIBD) | 1 | |
| Birth Location (VPD) | 1 | |
| Birth Outcome (Rubella) | 2 , 1 | |
| Birth Outcome (VPD) | 1 | |
| Birth or Delivery Occurred (NCHS) | 2 | |
| Blood Product | 1 | |
| Body Region(s) of Rash | 2 | |
| Body Site (FDD) | 1 | |
| Body site | 10 | |
| Botulinum Toxin Type (FDD) | 1 | |
| Botulism Food Source Type (FDD) | 1 | |
| Brucella Exposure (Brucellosis) | 2 | |
| Campylobacter Nonculture Test Type (BIDS) | 1 | |
| Case Classification Exposure Source | 2 | |
| Case Confirmation Method | 1 | |
| Case Detection Method | 3 , 2 , 1 | |
| Case Investigation Status | 3 | |
| Case Transmission Mode | 2 , 1 | |
| Case Transmission Mode (BIDS) | 1 | |
| Certifier Titles (NCHS) | 2 | |
| Certifier Types (NCHS) | 3 , 2 , 1 | |
| Character of Lesions | 2 | |
| Cholera Risk Factor (FDD) | 1 | |
| Cholera Sequelae (FDD) | 1 | |
| Cholera Signs Symptoms (FDD) | 1 | |
| Clinical Finding (COVID-19) | 1 | |
| Clinical Finding (NNDSS) | 2 | |
| Clinical Manifestation (TBRD) | 3 , 2 , 1 | |
| Clinical Manifestations (Anthrax) | 1 | |
| Clinical Manifestations (Babesiosis) | 2 | |
| Clinical Manifestations (Brucellosis) | 1 | |
| Clinical Manifestations (Leptospirosis) | 2 , 1 | |
| Clinical Manifestations (Lyme) | 1 | |
| Clinical Outcome (Anthrax) | 1 | |
| Clinical Syndrome (Arbovirus) | 7 , 6 , 5 , 4 , 3 , 2 | |
| Clinical Syndrome - Secondary (Arbovirus) | 2 , 1 | |
| Coinfection Type (TBRD) | 1 | |
| College Living Situation (RIBD) | 2 , 1 | |
| Common-Source Outbreak (Hepatitis B) | 1 | |
| Common-Source Outbreak (Hepatitis C) | 1 | |
| Complications (Malaria) | 3 , 1 | |
| Complications (Mumps) | 7 , 6 , 5 , 4 | |
| Complications (Pertussis) | 3 | |
| Complications (TBRD) | 3 , 2 , 1 | |
| Contact Type (Anthrax) | 1 | |
| Contact Type (Brucellosis) | 1 | |
| Contact Type (COVID-19) | 1 | |
| Contact Type (FDD) | 1 | |
| Contact Type (Hepatitis A) | 1 | |
| Contact Type (Hepatitis B and C) | 1 | |
| Contact Type (RIBD) | 1 | |
| Contact Type Hepatitis A (NETSS) | 1 | |
| Country | 6 , 5 , 4 , 3 | |
| County | 7 , 6 | |
| Critical Infrastructure Sector (NND) | 1 | |
| Cruise Line (RIBD) | 1 | |
| Cyclosporiasis Signs Symptoms (FDD) | 1 | |
| Data Reporting Source (CO) | 2 , 1 | |
| Data Reporting Source (COVID-19) | 1 | |
| Day Care Setting (FDD) | 1 | |
| Death Location (Flu) | 1 | |
| Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) | 2 | |
| Detection Method (COVID-19) | 2 , 1 | |
| Detection Method (RIBD) | 1 | |
| Detection Method (STD) | 2 , 1 | |
| Diagnosed by (VZ) | 4 , 3 , 2 , 1 | |
| Diagnostic Test Finding (Anthrax) | 1 | |
| Discharge Location (RIBD) | 3 , 2 , 1 | |
| Disease Outcome Type (Leptospirosis) | 1 | |
| Disposition ED (NCHS) | 2 | |
| Disposition OPD (NCHS) | 1 | |
| Division Vital Statistics (County) | 1 | |
| Dose Unit (STD) | 3 , 2 , 1 | |
| Drinking Water (FDD) | 1 | |
| Drugs Used (STD) | 2 , 1 | |
| Duration Units (STD) | 2 , 1 | |
| E. coli Shiga Toxin (BIDS) | 1 | |
| E. coli Shiga Toxin Test Type (BIDS) | 1 | |
| Education (CO) | 1 | |
| Employment Status (ODH) | 1 | |
| Epidemiological Risk Factors (TB) | 6 , 5 , 4 , 3 , 2 , 1 | |
| Epilinked Case Type (VZ) | 3 | |
| Establishment Type (RIBD) | 1 | |
| Ethnicity Group including Unknown | 2 | |
| Exposure (NWS) | 3 , 2 , 1 | |
| Exposure Location (Brucellosis) | 1 | |
| Exposure Risk (EVD) | 1 | |
| Exposure Setting (COVID-19) | 2 , 1 | |
| Exposure Setting Master (RIBD) | 1 | |
| Exposure Site Category (CO) | 4 , 3 , 2 , 1 | |
| Exposure Source (Anthrax) | 1 | |
| Exposure Source (Brucellosis) | 4 , 3 | |
| Exposure Source (CO) | 3 , 2 , 1 | |
| Exposure Type (Leptospirosis) | 1 | |
| Extended Race Group (Listeria) | 1 | |
| Extreme Weather Type (CO) | 4 , 3 , 2 , 1 | |
| Fetal Neonatal Infection Type (FDD) | 1 | |
| Fetal Neonatal Specimen Type | 1 | |
| Fetal Presentations (NCHS) | 3 , 2 | |
| Fetal Remains Disposition Method (NCHS) | 1 | |
| Follow-up Attempt Outcome (NCHS) | 2 , 1 | |
| Food Allergy (Listeria) | 1 | |
| Food Cooking Method (FDD) | 1 | |
| Food Cooking Method (Trich) | 1 | |
| Food Processing Method (FDD) | 1 | |
| Food Processing Method (Trich) | 1 | |
| Food Product Consumed (Brucellosis) | 2 , 1 | |
| Frequency Duration Unit (Hansen) | 2 , 1 | |
| Fresh Berries (FDD) | 2 , 1 | |
| Fresh Herbs (FDD) | 2 , 1 | |
| Fresh Produce (FDD) | 2 , 1 | |
| Fresh Water or Mud Type (Leptospirosis) | 2 , 1 | |
| Fruit (Listeria) | 1 | |
| Gender Identity | 4 , 3 , 2 , 1 | |
| Gender Identity (USCDI) | 1 | |
| Gene Name (CP-CRE) | 4 , 3 , 2 , 1 | |
| Gene Name (CPO) | 1 | |
| Gene Name (TB) | 2 , 1 | |
| Generator Location (CO) | 4 , 3 , 2 , 1 | |
| Genotype (Measles) | 1 | |
| Genotype (Rubella) | 3 , 2 , 1 | |
| Geographic Location | 2 , 1 | |
| Geographic Region (NETSS) | 1 | |
| Glove Material (RIBD) | 1 | |
| H. influenzae Serotype (RIBD) | 1 | |
| Health Care Practice Type (TB) | 1 | |
| Healthcare Exposure Type (RIBD) | 2 , 1 | |
| Healthcare Occupation (COVID-19) | 2 , 1 | |
| Hispanic Ethnic Group (Listeria) | 1 | |
| Hospital Procedure (Anthrax) | 1 | |
| Hospital Procedure (Leptospirosis) | 2 , 1 | |
| ICD Codes List (CO) | 4 , 3 , 2 , 1 | |
| Identifier Type (NNDSS) | 1 | |
| IgG Test Type (VZ) | 1 | |
| IgM Test Type (VZ) | 1 | |
| Illness (Listeria) | 2 , 1 | |
| Immigration Status | 1 | |
| Immunization Funding Source (IIS) | 1 | |
| Immunization Information Source (CRS) | 4 , 3 , 2 , 1 | |
| Improper Handling Storage (FDD) | 1 | |
| Infection Type (RIBD) | 1 | |
| Infections During Pregnancy - Live Birth (NCHS) | 4 , 3 , 1 | |
| Infections During Pregnancy Fetal Death (NCHS) | 3 , 2 | |
| Information Source | 1 | |
| Injury Type (NETSS) | 1 | |
| Injury Type (VPD) | 1 | |
| Insurance Type (RIBD) | 1 | |
| Isolate Not Available EIP Test Reason | 1 | |
| Isolate Not Received Reason | 1 | |
| Isolate Not Sent To NARMS Reason | 1 | |
| Job Setting (COVID-19) | 1 | |
| LTBI Drug Regimen (TB) | 2 , 1 | |
| Lab Result (Babesiosis) | 5 | |
| Lab Test (Hansen) | 2 , 1 | |
| Lab Test Interpretation (Pertussis) | 5 , 4 , 3 | |
| Lab Test Interpretation (RIBD) | 2 , 1 | |
| Lab Test Interpretation (VPD) | 7 , 6 , 5 , 4 , 3 , 2 | |
| Lab Test Interpretation (Varicella) | 4 , 3 , 2 | |
| Lab Test Interpretation Master (RIBD) | 1 | |
| Lab Test Method (MDRO) | 3 , 2 , 1 | |
| Lab Test Method (RIBD) | 2 , 1 | |
| Lab Test Procedure (Measles) | 1 | |
| Lab Test Procedure (Mumps) | 1 | |
| Lab Test Procedure (Rubella) | 6 , 5 , 4 , 2 , 1 | |
| Lab Test Result Coded | 2 | |
| Lab Test Result Name | 10 | |
| Lab Test Type (Babesiosis) | 2 | |
| Lab Test Type (Leptospirosis) | 2 , 1 | |
| Lab Test Type (Lyme) | 1 | |
| Lab Test Type (Mumps) | 6 , 5 | |
| Lab Test Type (Pertussis) | 6 , 5 | |
| Language | 3 | |
| Legionella Diagnosis (RIBD) | 1 | |
| Legionella Exposure (RIBD) | 1 | |
| Legionella Exposure Setting (RIBD) | 2 , 1 | |
| Legionellosis Serogroup (RIBD) | 2 , 1 | |
| Lettuce Type (FDD) | 2 , 1 | |
| Living Situation (NNDSS) | 2 , 1 | |
| Living Situation (NWS) | 1 | |
| Location Type (Leptospirosis) | 2 , 1 | |
| Manufacturers Of Vaccines (NETSS) | 1 | |
| Maternal Infection (FDD) | 1 | |
| Meat Consumed Type (Trich) | 1 | |
| Meat Purchase Info (FDD) | 1 | |
| Meat Purchase Info (Trich) | 1 | |
| Medical History (FDD) | 1 | |
| Medical History (Listeria) | 1 | |
| Medication (Brucellosis) | 1 | |
| Medication (Leptospirosis) | 2 , 1 | |
| Medication (TB) | 3 , 2 , 1 | |
| Medication Administered (Anthrax) | 1 | |
| Medication Administered (FDD) | 1 | |
| Medication Administered (Hansen) | 1 | |
| Medication Frequency Unit (STD) | 2 , 1 | |
| Medication Missed (Malaria) | 1 | |
| Medication Pre-Treatment (RIBD) | 1 | |
| Medication Prophylaxis (Malaria) | 5 , 4 , 3 , 2 , 1 | |
| Medication Received (Lyme) | 3 , 2 , 1 | |
| Medication Received (TBRD) | 2 , 1 | |
| Medication Received (VZ) | 3 , 2 , 1 | |
| Medication Route (STD) | 2 | |
| Medication Treatment (Babesiosis) | 1 | |
| Medication Treatment (Flu) | 2 | |
| Medication Treatment (Malaria) | 5 , 4 , 3 , 2 , 1 | |
| Medication Treatment (STD) | 1 | |
| Methods of Disposition (NCHS) | 2 , 1 | |
| Microorganism (ARLN) | 1 | |
| Microorganism (NETSS) | 1 | |
| Microorganism (Pediatric Flu) | 1 | |
| Microorganism (RIBD) | 1 | |
| Microorganism (STD) | 1 | |
| Microscopic Exam Culture Site (TB) | 3 , 2 , 1 | |
| Molecular Test Methods (TB) | 1 | |
| N. meningitidis Serogroup (RIBD) | 2 , 1 | |
| Neurological Manifestation (STD) | 2 , 1 | |
| Non Paint Lead Source | 1 | |
| Non Pork Type (FDD) | 1 | |
| Non-Sterile Specimen (Pediatric Flu) | 1 | |
| Null Flavor (HL7 V3) | 1 | |
| Number of Cigarettes Smoked per Day (CO) | 1 | |
| Observation Method | 3 | |
| Organism (CP-CRE) | 3 , 2 | |
| Organism (CPO) | 1 | |
| Organism (Lyme) | 2 , 1 | |
| Organism (TBRD) | 2 , 1 | |
| Organism Name (Brucellosis) | 1 | |
| Organism Name (Leptospirosis) | 2 , 1 | |
| Outbreak Type (Hepatitis) | 2 | |
| Outdoor Activities | 1 | |
| PCR Specimen Source (CRS) | 2 , 1 | |
| PCR Specimen Source (VZ) | 3 , 2 , 1 | |
| Parotitis Laterality (Mumps) | 2 | |
| Patient Case Status (Hansen) | 1 | |
| Patient Epidemiological Risk Factors (Hepatitis A) | 5 , 4 , 3 , 2 , 1 | |
| Patient Epidemiological Risk Factors (Hepatitis B) | 6 , 5 , 4 , 3 , 2 | |
| Patient Epidemiological Risk Factors (Hepatitis C) | 5 , 4 , 3 , 2 , 1 | |
| Patient Type (Listeria) | 2 | |
| Performing Lab Type (Anthrax) | 1 | |
| Performing Lab Type (RIBD) | 1 | |
| Performing Lab Type (Trich) | 1 | |
| Performing Laboratory Type (Leptospirosis) | 1 | |
| Performing Laboratory Type (NWS) | 1 | |
| Performing Laboratory Type (VPD) | 1 | |
| Person/Organization Taking CO Reading (CO) | 1 | |
| Personal Protective Equipment (RIBD) | 1 | |
| Place of Death (NCHS) | 4 , 3 , 2 | |
| Poison Control Center Record (CO) | 2 , 1 | |
| Pork Type (FDD) | 1 | |
| Preferred Language | 1 | |
| Pregnancy Outcome (FDD) | 1 | |
| Pregnancy Outcome (Leptospirosis) | 1 | |
| Pregnancy Outcome (Listeria) | 2 , 1 | |
| Previous Case Diagnosed By (Rubella) | 2 , 1 | |
| Previous Treatment Duration (Hansen) | 1 | |
| Primary Reason For Evaluation (TB) | 3 , 2 | |
| Procedure Type (Anthrax) | 1 | |
| Public Site of Exposure (CO) | 4 , 3 , 2 , 1 | |
| Public TransportationType (Anthrax) | 1 | |
| Rash Location First Noted (VZ) | 1 | |
| Raw Unpasteurized Products (FDD) | 1 | |
| Reason For Test (Hepatitis) | 2 , 1 | |
| Reason LTBI Not Started (TB) | 2 , 1 | |
| Reason LTBI Treatment Stopped (TB) | 1 | |
| Reason Medication Not Completed (BSP) | 1 | |
| Reason Not Interviewed (Listeria) | 1 | |
| Reason Not Treated with RIPE (TB) | 3 , 2 , 1 | |
| Reason Therapy Stopped (TB) | 3 , 2 , 1 | |
| Reason for Hospitalization (VZ) | 3 , 2 , 1 | |
| Reason for Test (COVID-19) | 1 | |
| Recreational Water (FDD) | 1 | |
| Relationship (Hansen) | 2 , 1 | |
| Relationship (VPD) | 1 | |
| Reporting Lab Type | 1 | |
| Reporting Source Type | 2 | |
| Residence Location (RIBD) | 3 , 2 , 1 | |
| Residence Type (COVID-19) | 1 | |
| Residential Site of Exposure (CO) | 3 , 2 , 1 | |
| Respiratory Protective Equipment (RIBD) | 1 | |
| Risk Factor (COVID-19) | 3 , 2 , 1 | |
| Risk Factors (TB) | 1 | |
| Rodent Type (Leptospirosis) | 1 | |
| Route Of Administration (IIS) | 2 | |
| Route of Administration (STD) | 2 , 1 | |
| SPN/IPD Serotype (RIBD) | 2 , 1 | |
| STEC Nonculture Test Type (BIDS) | 1 | |
| Salmonella Serogroup (BIDS) | 1 | |
| School Year (RIBD) | 1 | |
| Seafood Preparation (FDD) | 2 , 1 | |
| Seafood Purchase Info (FDD) | 1 | |
| Seafood Source (FDD) | 1 | |
| Seafood Type (FDD) | 3 | |
| Sequelae (RIBD) | 2 , 1 | |
| Serogroup (NETSS) | 1 | |
| Serogroup Method (RIBD) | 1 | |
| Serotype (NETSS) | 1 | |
| Serotype Master (RIBD) | 1 | |
| Serotype Method (RIBD) | 1 | |
| Setting of Further Spread | 1 | |
| Severe Weather Type (Leptospirosis) | 2 | |
| Sexual Orientation | 2 , 1 | |
| Sexual Orientation (Hepatitis) | 1 | |
| Sexual Orientation (STD) | 1 | |
| Sexual Orientation (USCDI) | 1 | |
| Shellfish Distributed (FDD) | 1 | |
| Sick Animal Type (Leptospirosis) | 1 | |
| Side Effect of Treatment (TB) | 1 | |
| Signs Symptoms (CS) | 1 | |
| Signs and Symptoms (CO) | 1 | |
| Signs and Symptoms (COVID-19) | 2 , 1 | |
| Signs and Symptoms (FDD) | 2 , 1 | |
| Signs and Symptoms (Hepatitis) | 1 | |
| Signs and Symptoms (Listeria) | 1 | |
| Signs and Symptoms (Measles) | 3 | |
| Signs and Symptoms (Mumps) | 3 , 2 | |
| Signs and Symptoms (Pertussis) | 4 | |
| Signs and Symptoms (RIBD) | 2 , 1 | |
| Signs and Symptoms (Rubella) | 3 | |
| Signs and Symptoms (Trich) | 1 | |
| Skin Exposure Activity (FDD) | 1 | |
| Source of Laboratory Test (Hepatitis) | 3 , 2 , 1 | |
| Species (Malaria) | 1 | |
| Specimen | 13 | |
| Specimen (Flu) | 2 , 1 | |
| Specimen Collection Setting Type (C. auris) | 2 , 1 | |
| Specimen Collection Site AST (STD) | 1 | |
| Specimen Collection Source (FDD) | 3 , 2 , 1 | |
| Specimen Reshipment Reason | 1 | |
| Specimen Site (BIDS) | 1 | |
| Specimen Site (FDD) | 1 | |
| Specimen Source (C. auris) | 1 | |
| Specimen Source (CP-CRE) | 1 | |
| Specimen Source (CRS) | 2 , 1 | |
| Specimen Source (Measles) | 1 | |
| Specimen Source (Mumps) | 1 | |
| Specimen Source (Rubella) | 2 , 1 | |
| Specimen Source (STD) | 2 , 1 | |
| Specimen Source (VPD) | 1 | |
| Specimen Source Site (Anthrax) | 1 | |
| Specimen Source Site (Brucellosis) | 1 | |
| Specimen Source Site (Leptospirosis) | 1 | |
| Specimen Source Site (VPD) | 1 | |
| Specimen Type (Anthrax) | 1 | |
| Specimen Type (Brucellosis) | 1 | |
| Specimen Type (CRS) | 2 , 1 | |
| Specimen Type (Leptospirosis) | 2 , 1 | |
| Specimen Type (Listeria) | 1 | |
| Specimen Type (Lyme) | 2 , 1 | |
| Specimen Type (Malaria) | 2 , 1 | |
| Specimen Type (RIBD) | 4 , 3 , 2 , 1 | |
| Specimen Type (Rubella) | 2 , 1 | |
| Specimen Type (TBRD) | 1 | |
| Specimen Type AST (STD) | 1 | |
| Specimen type (ARLN) | 1 | |
| Specimen type (Trich) | 1 | |
| Sputum Culture Conversion Not Documented Reason | 2 , 1 | |
| Sterile Specimen (IPD) | 2 , 1 | |
| Sterile Specimen (Pediatric Flu) | 1 | |
| Strain Type (Trich) | 3 , 2 , 1 | |
| Substance Abuse (RIBD) | 3 , 2 , 1 | |
| Substance Treatment Refusal Reason | 1 | |
| Susceptibility Data NA (RIBD) | 1 | |
| Susceptibility Test Method (TB) | 1 | |
| Swimming Pool Type (FDD) | 1 | |
| Symptoms (EVD Triage) | 1 | |
| Symptoms (NWS) | 3 , 2 , 1 | |
| Syphilis Clinical Stage (CS) | 1 | |
| Syphilis Surveillance Stage (CS) | 2 , 1 | |
| Syphilis Treatment Mother (CS) | 1 | |
| Tap Water Source (FDD) | 1 | |
| Tattoo Obtained From (Hepatitis) | 2 , 1 | |
| Test Method (FDD) | 4 , 3 , 2 | |
| Test Method EIA IgM | 1 | |
| Test Results (Leptospirosis) | 1 | |
| Test Results Anthrax | 1 | |
| Test Titer Type (Brucellosis) | 1 | |
| Test Type (Brucellosis) | 2 , 1 | |
| Test Type (FDD) | 2 , 1 | |
| Therapy Extended Reason (TB) | 3 , 2 , 1 | |
| Timing of Maternal Treatment (NND) | 2 | |
| Titer Test Method (RIBD) | 1 | |
| Transmission Setting (NETSS) | 1 | |
| Transmission Setting (NND) | 3 , 2 , 1 | |
| Transportation Relationships (NCHS) | 2 | |
| Travel Purpose | 2 , 1 | |
| Travel Purpose (CDC) | 1 | |
| Travel Reason (Hepatitis A) | 1 | |
| Travel Reason (Malaria) | 4 , 3 , 2 , 1 | |
| Travelers Health Info Source | 1 | |
| Treatment Type (Anthrax) | 1 | |
| Treatment Type (CO) | 1 | |
| Treatment Type (COVID-19) | 2 , 1 | |
| Treponemal Serologic Test (STD) | 2 , 1 | |
| Tribe Name (NND) | 2 , 1 | |
| Trichinellosis Signs Symptoms (FDD) | 1 | |
| Type Of Complication (CRS) | 4 , 3 , 2 , 1 | |
| Type Of Complication (Rubella) | 4 , 3 , 2 , 1 | |
| Type of Co-infection (C. auris) | 2 , 1 | |
| Type of Complication (Babesiosis) | 1 | |
| Type of Complication (Measles) | 2 , 1 | |
| Type of Complication (STD) | 2 , 1 | |
| Type of Complication (VZ) | 2 | |
| Type of Correctional Facility | 3 , 2 | |
| Type of Deafness (Mumps) | 2 | |
| Type of Leprosy (Hansen) | 2 , 1 | |
| Type of Link (TB) | 1 | |
| Type of Long Term Care Facility | 3 , 2 | |
| Type of Long Term Care Facility (C. auris) | 1 | |
| Type of Radiology Study | 1 | |
| Type of Testing at CDC | 2 , 1 | |
| Type of Testing at CDC (NND) | 1 | |
| Type of Testing at CDC (VZ) | 1 | |
| Type of Testing at CDC(Rubella) | 1 | |
| Typhoid Signs Symptoms (FDD) | 1 | |
| Underlying Condition (RIBD) | 2 , 1 | |
| Underlying Condition(s) (Leptospirosis) | 2 , 1 | |
| Underlying Conditions | 1 | |
| Underlying Conditions (CO) | 3 , 2 , 1 | |
| Underlying Conditions (IPD) | 2 , 1 | |
| Underlying Conditions (Pediatric Flu) | 1 | |
| Usual Occupation and Industry (TB) | 1 | |
| VPD Laboratory Coded Observation | 1 | |
| VPD Specimen Type | 6 , 5 , 4 | |
| Vaccination Information Source (RIBD) | 2 , 1 | |
| Vaccination Location (CRA) | 1 | |
| Vaccine Administered (MMR) | 2 | |
| Vaccine Administered (Pertussis) | 2 | |
| Vaccine Event Information Source (NND) | 3 , 2 , 1 | |
| Vaccine Exposure (Brucellosis) | 1 | |
| Vaccine Not Given Reason | 3 , 2 , 1 | |
| Vaccine Not Given Reasons (NETSS) | 1 | |
| Vaccine Purchased With Funds | 1 | |
| Vaccine Type (NND) | 13 , 12 , 11 , 10 , 9 , 8 , 7 , 6 , 5 , 4 , 3 , 2 | |
| Vaccine Type (RIBD) | 2 , 1 | |
| Vaccines Administered (NETSS) | 1 | |
| Vaccines Administered (VZ) | 2 | |
| Vibrio Cholera Toxin Test Type (BIDS) | 1 | |
| Vibrio Culture Species (BIDS) | 1 | |
| Vibrio Species (FDD) | 3 , 2 , 1 | |
| Virus Variant Type (Animal Rabies) | 2 , 1 | |
| Water Salinity (FDD) | 1 | |
| Water Source (RIBD) | 1 | |
| Work Schedule (ODH) | 1 | |
| Workers Compensation Record (CO) | 2 , 1 | |